Syros Pharmaceuticals Inc. [NASDAQ: SYRS] stock went on a downward path that fall over -61.68% on Tuesday, amounting to a one-week price decrease of less than -64.11%.
Over the last 12 months, SYRS stock dropped by -49.74%. The one-year Syros Pharmaceuticals Inc. stock forecast points to a potential upside of 78.06. The average equity rating for SYRS stock is currently 1.00, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $51.32 million, with 26.45 million shares outstanding and 19.89 million shares in the current float. Compared to the average trading volume of 119.91K shares, SYRS stock reached a trading volume of 4801981 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Syros Pharmaceuticals Inc. [SYRS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SYRS shares is $8.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SYRS stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Syros Pharmaceuticals Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 04, 2020. While these analysts kept the previous recommendation, Alliance Global Partners raised their target price to Buy. The new note on the price target was released on September 22, 2020, representing the official price target for Syros Pharmaceuticals Inc. stock.
The Average True Range (ATR) for Syros Pharmaceuticals Inc. is set at 0.63, with the Price to Sales ratio for SYRS stock in the period of the last 12 months amounting to 12.37.
SYRS Stock Performance Analysis:
Syros Pharmaceuticals Inc. [SYRS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -64.11. With this latest performance, SYRS shares dropped by -68.73% in over the last four-week period, additionally sinking by -72.69% over the last 6 months – not to mention a drop of -49.74% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SYRS stock in for the last two-week period is set at 17.40, with the RSI for the last a single of trading hit 11.23, and the three-weeks RSI is set at 22.68 for Syros Pharmaceuticals Inc. [SYRS]. The present Moving Average for the last 50 days of trading for this stock 5.53, while it was recorded at 4.44 for the last single week of trading, and 5.47 for the last 200 days.
Insight into Syros Pharmaceuticals Inc. Fundamentals:
Syros Pharmaceuticals Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.46 and a Current Ratio set at 3.46.
Syros Pharmaceuticals Inc. [SYRS] Institutonal Ownership Details
The top three institutional holders of SYRS stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in SYRS stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in SYRS stock with ownership which is approximately 5.1238%.
